ArticleOncoTargets and therapy2024

Response to Savolitinib in a Patient with Advanced Poorly Differentiated Lung Carcinoma Positive for a Novel EML4-MET Gene Fusion.

Ganlu Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.